Zhong et al. reported higher BACE1 activity in patients with mild cognitive impairment compared to Alzheimer disease patients and controls, and elevated BACE1 protein concentration was related to increased risk for Alzheimer’s disease [94]. This evidence concerns the gene BACE1 and Cognitive impairment.